Piramal Pharma Solutions

Piramal Pharma Solutions PPS is a CDMO offering end-to-end development and manufacturing solutions across the drug lifecycle.

We serve our clients through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs, and Finished dosage forms. We also offer specialized services like the development and manufactur

e of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more information and updates, please visit: www.piramalpharmasolutions.com

We’re excited to be attending the BIO International Convention again this year!Visit us at Booth 4643 to connect with ou...
06/04/2026

We’re excited to be attending the BIO International Convention again this year!

Visit us at Booth 4643 to connect with our team and learn how we’re advancing patient-centric innovation across the biotech and life sciences landscape.

Our Chief Commercial Officer & Chief Patient Centricity Officer, Stuart Needleman will both be available onsite for meetings, conversations, and walk-ins throughout the event.

Whether you're exploring new partnerships, discussing commercialization strategy, or looking to improve patient engagement outcomes, we’d love to connect.

Booth 4643
Walk-ins welcome
June 22 - 25, 2026 | San Diego, CA
See you at BIO!

Advancing innovative science starts with strong discovery partnerships.Join Anne P. at The 60th International Conference...
06/03/2026

Advancing innovative science starts with strong discovery partnerships.

Join Anne P. at The 60th International Conference on Medicinal Chemistry (RICT 2026) in Paris, where she will be representing Piramal Discovery Solutions and showcasing our end-to-end discovery capabilities.

From medicinal chemistry and integrated biology to DMPK and lead optimization, our teams work collaboratively with biotech and pharmaceutical innovators to help accelerate the path from concept to candidate.

Stop by at Tabletop TB5

July 1–3, 2026
La Maison de la Chimie, Paris

Let's discuss how Piramal Discovery Solutions can help move your next program forward with speed, flexibility, and scientific excellence.

The future of antibody-drug conjugates continues to evolve—and we're excited to be part of the conversation at World ADC...
06/03/2026

The future of antibody-drug conjugates continues to evolve—and we're excited to be part of the conversation at World ADC Korea.

Visit Booth #19 to discover how Piramal Pharma Solutions supports ADC innovators with integrated development and manufacturing solutions, from potent payloads and linker-payload synthesis to antibody conjugation, analytical development, and commercial manufacturing.

Our experts will be available throughout the event to discuss strategies for advancing ADC programs efficiently and confidently.

Booth #19
World ADC Korea

Piramal Pharma Solutions is looking forward to participating in BIO International Convention 2026 alongside global leade...
06/03/2026

Piramal Pharma Solutions is looking forward to participating in BIO International Convention 2026 alongside global leaders and innovators from across the biopharma industry.

As conversations around innovation and collaboration continue to shape the future of healthcare, we’re excited to connect with partners and peers to share insights across integrated development and manufacturing solutions for complex programs.

Our team will be present throughout the event, engaging in meaningful discussions around scientific expertise, scalable pathways, and evolving industry needs, all while welcoming visitors to our coffee bar setup for conversations over a fresh brew.

Here's to yet another unforgettable experience in addition to driving meaningful conversations forward!

🗓️ 22-25 June
📍San Diego Convention Center

Behind every successful API program is the right technical support.At CPhI Americas 2026, meet John Riley, Director, Nor...
06/03/2026

Behind every successful API program is the right technical support.

At CPhI Americas 2026, meet John Riley, Director, North America API Technical Support at Piramal Pharma Solutions.

John works closely with teams and partners to solve complex API challenges, from process understanding to purification strategies ensuring programs move forward with confidence.

Connect with us at Booth 736 at the Pennsylvania Convention Center

Watch his video as he explores diverse chromatography applications, techniques, and benefits to help you gain a deeper understanding of this critical tool.

https://lnkd.in/dKDSPdbd

Biocatalysis is playing an increasingly important role in enabling more selective, efficient, and sustainable pathways i...
05/26/2026

Biocatalysis is playing an increasingly important role in enabling more selective, efficient, and sustainable pathways in drug discovery.

At Piramal Discovery Solutions in Ahmedabad, we leverage biocatalytic approaches to design greener and highly selective transformations supporting both early discovery and scale-up.

Our lab-scale development utilizes controlled systems such as glass reactors and incubator-based setups for whole-cell reactions, while scale-up is enabled through jacketed reactors with in-line monitoring of pH and temperature across aqueous, biphasic, and co-solvent systems.

Some of the ways we apply biocatalysis include:
- Chiral alcohol synthesis using alcohol dehydrogenases (ADHs) for enantiopure intermediates
- Kinetic resolution via lipase-catalyzed transesterification of racemates
- Green epoxidation using peroxygenases, avoiding heavy metals while maintaining high selectivity
- API amination through transaminases to access chiral amines

By integrating biocatalysis into our broader chemistry toolkit, we enable more sustainable and precise routes to complex molecules helping our partners accelerate innovation with efficiency and responsibility.

Not all molecules are straightforward, and that’s where expertise matters.Meet Brad Gold, Global Head of Formulations R&...
05/25/2026

Not all molecules are straightforward, and that’s where expertise matters.

Meet Brad Gold, Global Head of Formulations R&D, at CPhI Americas 2026.

From solubility and bioavailability challenges to scale-up considerations, Brad works with partners to design formulation strategies that enable success across development stages.

Bring your toughest formulation questions, we’re ready to solve them together.

Pennsylvania Convention Center
Booth 736

Antibody-drug conjugates (ADCs) are at the forefront of oncology innovation, combining targeted delivery with potent the...
05/22/2026

Antibody-drug conjugates (ADCs) are at the forefront of oncology innovation, combining targeted delivery with potent therapeutic action to improve treatment outcomes.

With advancements across payload design, linker chemistry, and conjugation technologies, ADC pharma is evolving rapidly unlocking new possibilities across cancer care.

As complexity grows, integrated development models are becoming essential. At Piramal Pharma Solutions, we bring together expertise across the ADC lifecycle to help simplify development and accelerate progress from concept to commercialization.

Click on the link below to read the full story on our blog:
https://lnkd.in/dgZpgdrS

Not just one molecule, your entire pipeline.Meet Daniel Weissmueller, Director, Business Development, at CPhI Americas 2...
05/20/2026

Not just one molecule, your entire pipeline.

Meet Daniel Weissmueller, Director, Business Development, at CPhI Americas 2026.

Daniel works with partners to align development and manufacturing strategies across their portfolios ensuring consistency, efficiency, and scalability from early-stage assets to commercial programs.

Let’s talk about how we can support your pipeline, end-to-end.

Pennsylvania Convention Center
Booth 736
Schedule a meeting with our team in advance: [email protected].

Earlier this month, leading Indian companies attended the 2026 SelectUSA Investment Summit, where they pledged over $20....
05/19/2026

Earlier this month, leading Indian companies attended the 2026 SelectUSA Investment Summit, where they pledged over $20.5 billion to the US pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies industries.

With over $19.1 billion of that total comprising investments from Indian pharma into US manufacturing, research, and development, and facility expansions, these contributions are expected to generate thousands of jobs and boost innovation in both regions.

At Piramal Pharma Solutions, we’re proud to be at the forefront of these plans, building on our longstanding commitment to US-based development and manufacturing. Over the last year, we’ve been rolling out a $90 million investment plan across our US facilities to deliver greater speed, scalability, and supply chain security to our partners — and we’re just getting started.

Discover how our US-based facilities have grown, and learn how they can accelerate your success at the links below.

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/210825073135-Piramal-Pharma-Solutions-and-NewAmsterdam-Pharma-Invest-in-Dedicated-Suite-to-Enhance-Oral-Solid-Dosage-Production-Capabilities.pdf

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/300625065655-Lexington-Expansion-Groundbreaking-Press-Release-Final.pdf

-https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/120525115627-Piramal-Pharma-Ltd-Continues-to-Invest-In-USA.pdf

- https://www.piramalpharmasolutions.com/contact-us

Address

18655 Krause Street
Riverview, MI
48193

Website

Alerts

Be the first to know and let us send you an email when Piramal Pharma Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category